Pharma industry invests £377m in UK R&D collabs
ABPI chief said that the investment from companies is “excellent news at a time of economic uncertainty and signals the strength of the sector in the UK.”
Read More
Tag: collaborations
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
